Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000986205 | SCV001135129 | likely pathogenic | Progressive myoclonic epilepsy type 8 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000986205 | SCV001488893 | uncertain significance | Progressive myoclonic epilepsy type 8 | 2022-01-04 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 255 of the CERS1 protein (p.Arg255Cys). This variant is present in population databases (no rsID available, gnomAD 0.001%). This missense change has been observed in individual(s) with progressive myoclonic epilepsy (PMID: 30800706). ClinVar contains an entry for this variant (Variation ID: 801420). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000986205 | SCV002106394 | pathogenic | Progressive myoclonic epilepsy type 8 | 2022-03-18 | no assertion criteria provided | literature only |